Concerning the T2DM treatments, 105 (57.7%) subjects were on oral therapies, and 77 (42.3%) on insulin treatment, either alone (71 cases) or in combination (6 cases) with oral hypoglycaemic drugs. The gene discussed is INS; the disease is type 2 diabetes mellitus.